{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T10:28:08Z","timestamp":1787480888847,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM102864"],"award-info":[{"award-number":["GM102864"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytical Biochemistry"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ab.2014.12.022","type":"journal-article","created":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T21:50:08Z","timestamp":1423864208000},"page":"40-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A [32P]NAD+-based method to identify and quantitate long residence time enoyl-acyl carrier protein reductase inhibitors"],"prefix":"10.1016","volume":"474","author":[{"given":"Weixuan","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Neckles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal Reddy","family":"Bommineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Spagnuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Truglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Tonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ab.2014.12.022_b0005","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1126\/science.321.5887.356","article-title":"The bacteria fight back","volume":"321","author":"Taubes","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ab.2014.12.022_b0010","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0966-842X(01)02235-1","article-title":"Exploiting genomics to discover new antibiotics","volume":"9","author":"McDevitt","year":"2001","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ab.2014.12.022_b0015","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1126\/science.321.5887.362","article-title":"Trench warfare in a battle with TB","volume":"321","author":"Marshall","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ab.2014.12.022_b0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrmicro1614","article-title":"The antibiotic resistome: the nexus of chemical and genetic diversity","volume":"5","author":"Wright","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ab.2014.12.022_b0025","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nrd2082","article-title":"Drug\u2013target residence time and its implications for lead optimization","volume":"5","author":"Copeland","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ab.2014.12.022_b0030","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1021\/bi8002023","article-title":"Residence time of receptor-ligand complexes and its effect on biological function","volume":"47","author":"Tummino","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.ab.2014.12.022_b0035","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1476-5381.2010.00936.x","article-title":"Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action","volume":"161","author":"Vauquelin","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ab.2014.12.022_b0040","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates?","volume":"3","author":"Kola","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ab.2014.12.022_b0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1021\/cb800306y","article-title":"Slow-onset inhibition of the FabI enoyl reductase from Francisella tularensis: residence time and in vivo activity","volume":"4","author":"Lu","year":"2009","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ab.2014.12.022_b0050","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cbpa.2010.06.176","article-title":"Drug\u2013target residence time: critical information for lead optimization","volume":"14","author":"Lu","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ab.2014.12.022_b0055","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/bi048632b","article-title":"Mechanism of time-dependent inhibition of polypeptide deformylase by actinonin","volume":"44","author":"Van Aller","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.ab.2014.12.022_b0060","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ab.2011.05.029","article-title":"Impact of enzyme concentration and residence time on apparent activity recovery in jump dilution analysis","volume":"416","author":"Copeland","year":"2011","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ab.2014.12.022_b0065","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1021\/bi900038p","article-title":"Inhibition and binding kinetics of the hepatitis C virus NS3 protease inhibitor ITMN-191 reveals tight binding and slow dissociative behavior","volume":"48","author":"Rajagopalan","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.ab.2014.12.022_b0070","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/jmr.675","article-title":"Advances in membrane receptor screening and analysis","volume":"17","author":"Cooper","year":"2004","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.ab.2014.12.022_b0075","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0958-1669(99)00054-3","article-title":"Advances in surface plasmon resonance biosensor analysis","volume":"11","author":"Rich","year":"2000","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.ab.2014.12.022_b0080","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1461-5347(00)00288-1","article-title":"Implementing surface plasmon resonance biosensors in drug discovery","volume":"3","author":"Myszka","year":"2000","journal-title":"Pharm. Sci. Technol. Today"},{"key":"10.1016\/j.ab.2014.12.022_b0085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ab.2008.03.035","article-title":"Determining kinetics and affinities of protein interactions using a parallel real-time label-free biosensor, the Octet","volume":"377","author":"Abdiche","year":"2008","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ab.2014.12.022_b0090","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ab.2005.09.034","article-title":"Analyzing a kinetic titration series using affinity biosensors","volume":"349","author":"Karlsson","year":"2006","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ab.2014.12.022_b0095","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1063\/1.1523649","article-title":"High-performance differential surface plasmon resonance sensor using quadrant cell photodetector","volume":"74","author":"Zhang","year":"2003","journal-title":"Rev. Sci. Instrum."},{"key":"10.1016\/j.ab.2014.12.022_b0100","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1016\/S0021-9258(17)40446-7","article-title":"Reversible binding of Pi by beef heart mitochondrial adenosine triphosphatase","volume":"252","author":"Penefsky","year":"1977","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2014.12.022_b0105","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0076-6879(79)56050-9","article-title":"A centrifuged-column procedure for the measurement of ligand binding by beef heart F1","volume":"56","author":"Penefsky","year":"1979","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ab.2014.12.022_b0110","doi-asserted-by":"crossref","first-page":"39835","DOI":"10.1074\/jbc.M110.141580","article-title":"Hsp90 (heat shock protein 90) inhibitor occupancy is a direct determinant of client protein degradation and tumor growth arrest in vivo","volume":"285","author":"Tillotson","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2014.12.022_b0115","doi-asserted-by":"crossref","first-page":"8235","DOI":"10.1021\/bi00026a004","article-title":"Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis","volume":"34","author":"Quemard","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.ab.2014.12.022_b0120","doi-asserted-by":"crossref","first-page":"12514","DOI":"10.1021\/bi9907779","article-title":"Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan","volume":"38","author":"Ward","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.ab.2014.12.022_b0125","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jac\/dkq509","article-title":"Mechanism and inhibition of the FabI enoyl-ACP reductase from Burkholderia pseudomallei","volume":"66","author":"Liu","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ab.2014.12.022_b0130","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1021\/bi800023a","article-title":"Mechanism and inhibition of saFabI, the enoyl reductase from Staphylococcus aureus","volume":"47","author":"Xu","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.ab.2014.12.022_b0135","doi-asserted-by":"crossref","first-page":"14330","DOI":"10.1074\/jbc.M109.090373","article-title":"A slow, tight binding inhibitor of InhA, the enoyl-acyl carrier protein reductase from Mycobacterium tuberculosis","volume":"285","author":"Luckner","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2014.12.022_b0140","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.str.2012.03.013","article-title":"Staphylococcus aureus Fab I: inhibition, substrate recognition, and potential implications for in vivo essentiality","volume":"20","author":"Schiebel","year":"2012","journal-title":"Structure"},{"key":"10.1016\/j.ab.2014.12.022_b0145","doi-asserted-by":"crossref","first-page":"13623","DOI":"10.1021\/bi990529c","article-title":"Roles of tyrosine 158 and lysine 165 in the catalytic mechanism of InhA, the enoyl-ACP reductase from Mycobacterium tuberculosis","volume":"38","author":"Parikh","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.ab.2014.12.022_b0235","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1016\/j.bmcl.2008.04.038","article-title":"Synthesis and in vitro antimycobacterial activity of B-ring modified diaryl ether InhA inhibitors","volume":"18","author":"am Ende","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ab.2014.12.022_b0155","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1021\/jm030182i","article-title":"Inhibition of the bacterial enoyl reductase FabI by triclosan: a structure\u2013reactivity analysis of FabI inhibition by triclosan analogues","volume":"47","author":"Sivaraman","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ab.2014.12.022_b0160","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1021\/cb0500042","article-title":"High affinity InhA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosis","volume":"1","author":"Sullivan","year":"2006","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ab.2014.12.022_b0165","unstructured":"P. Pan, Lead optimization and slow-onset inhibition of the enoyl-ACP reductase (InhA) from Mycobacterium tuberculosis (Ph.D. dissertation), Stony Brook University, 2012."},{"key":"10.1016\/j.ab.2014.12.022_b0170","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1021\/bi400413c","article-title":"Rational optimization of drug\u2013target residence time: insights from inhibitor binding to the Staphylococcus aureus FabI enzyme\u2013product complex","volume":"52","author":"Chang","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.ab.2014.12.022_b0175","doi-asserted-by":"crossref","first-page":"13881","DOI":"10.1073\/pnas.2235848100","article-title":"The isoniazid\u2013NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance","volume":"100","author":"Rawat","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ab.2014.12.022_b0180","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2210-12-2","article-title":"Potency, selectivity, and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor","volume":"12","author":"Wang","year":"2012","journal-title":"BMC Pharmacol."},{"key":"10.1016\/j.ab.2014.12.022_b0185","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1042\/BJ20090121","article-title":"Biochemical characterization of GSK1070916, a potent and selective inhibitor of Aurora B and Aurora C kinases with an extremely long residence time1","volume":"420","author":"Anderson","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.ab.2014.12.022_b0190","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1021\/bi802141y","article-title":"Potent inhibitors of HIV-1 integrase display a two-step, slow-binding inhibition mechanism which is absent in a drug-resistant T66I\/M154I mutant","volume":"48","author":"Garvey","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.ab.2014.12.022_b0195","series-title":"Evaluation of enzyme inhibitors in drug discovery: a guide for medicinal chemists and pharmacologists","author":"Copeland","year":"2005"},{"key":"10.1016\/j.ab.2014.12.022_b0200","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1517\/17460441.2012.687720","article-title":"Radioligand dissociation measurements: potential interference of rebinding and allosteric mechanisms and physiological relevance of the biological model systems","volume":"7","author":"Vauquelin","year":"2012","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ab.2014.12.022_b0205","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/clinchem\/32.2.314","article-title":"Stability of NADPH: effect of various factors on the kinetics of degradation","volume":"32","author":"Wu","year":"1986","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ab.2014.12.022_b0210","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1007\/s00216-010-4111-z","article-title":"Structure elucidation of the thermal degradation products of the nucleotide cofactors NADH and NADPH by nano-ESI\u2013FTICR\u2013MS and HPLC\u2013MS","volume":"398","author":"Hofmann","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ab.2014.12.022_b0215","doi-asserted-by":"crossref","first-page":"7625","DOI":"10.1073\/pnas.0602650103","article-title":"A biochemical rationale for the anticancer effects of Hsp90 inhibitors: slow, tight binding inhibition by geldanamycin and its analogues","volume":"103","author":"Gooljarsingh","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ab.2014.12.022_b0220","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1177\/1087057111418113","article-title":"Multidimensional profiling of CSF1R screening hits and inhibitors: assessing cellular activity, target residence time, and selectivity in a higher throughput way","volume":"16","author":"Uitdehaag","year":"2011","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.ab.2014.12.022_b0225","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1039\/C2MD20015E","article-title":"Determination of drug\u2013receptor residence times by radioligand binding and functional assays: experimental strategies and physiological relevance","volume":"3","author":"Vauquelin","year":"2012","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ab.2014.12.022_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-895X(25)15016-5","article-title":"The kinetics of competitive radioligand binding predicted by the law of mass action","volume":"25","author":"Motulsky","year":"1984","journal-title":"Mol. Pharmacol."}],"container-title":["Analytical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269715000056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269715000056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T21:14:05Z","timestamp":1757711645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003269715000056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":46,"alternative-id":["S0003269715000056"],"URL":"https:\/\/doi.org\/10.1016\/j.ab.2014.12.022","relation":{},"ISSN":["0003-2697"],"issn-type":[{"value":"0003-2697","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A [32P]NAD+-based method to identify and quantitate long residence time enoyl-acyl carrier protein reductase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Analytical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ab.2014.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}